Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
88.11 CHF | +0.16% | -0.66% | +4.02% |
10:44am | NOVARTIS AG : UBS maintains a Buy rating | ZD |
05-02 | Health Care Flat Amid Mixed Earnings -- Health Care Roundup | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.02% | 198B | |
+28.52% | 662B | |
+22.36% | 546B | |
-4.75% | 359B | |
+16.92% | 323B | |
+4.73% | 289B | |
+13.68% | 234B | |
-10.39% | 194B | |
+4.92% | 167B | |
-2.34% | 157B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis' Cosentyx Cuts Inflammatory Lesions in Two Late-Stage Skin Disorder Studies